达纳康对脑梗塞康复期的治疗作用

45例脑梗塞康复期患者采用口服达纳康片或肠溶阿斯匹林片治疗以对比观察达纳康对脑梗塞后脑功能障碍的康复治疗作用。应用脑卒中功能障碍评估法、听觉事件相关诱发电位和血液流变学等为评估指标。结果：口服达纳康片3个月后，患者的脑卒中功能障碍评估法评分提高，听觉事件相关诱发电位和血液流变学指数改善，与阿斯匹林片组比较，差异有显著性，P＜0.01，0.05。提示达纳康是脑梗塞患者低血压状态的良好调节剂，其主要作用机理可能源于改善血液流变学指数和“三血管调节”作用。

Treatment of Tanakan to Cerebral Infarction Patients in Rehabilitation Stage

Forty-five cases of cerebral infarction in rehabilitation stage were divided into two groups: receiving Tanakan or aspirin respectively to comparatively observe the treatment of Tanakan to the patients with cerebral infarction. SIAS, P300, and blood rheology were used as the assessment indices. The results showed that Tanakan could incrcase SIAS scores, improve P300 and blood rheology indices. There was a significant difference in the therapeutic effects between the Tanakan-treated gropu and aspirin-treated group. It was suggestcd that Tanakan is a good regulator for hypotension status in the patients with cerebral infarction in the rehabilitation stage, and its main mechanism might be contributed to the improvement of blood rheology index and the action of the "trivessel regulation".